南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2010年
1期
143-145
,共3页
吴军%张源源%冯德光%徐丞%熊日成%俞宙%郭振辉%苏磊
吳軍%張源源%馮德光%徐丞%熊日成%俞宙%郭振輝%囌磊
오군%장원원%풍덕광%서승%웅일성%유주%곽진휘%소뢰
老年人%脓毒症%甲状腺激素%单核细胞人白细胞抗原-DR
老年人%膿毒癥%甲狀腺激素%單覈細胞人白細胞抗原-DR
노년인%농독증%갑상선격소%단핵세포인백세포항원-DR
senior patients%sepsis%thyroxin%human leukocyte antigen DR
目的 探讨老年脓毒症患者血清甲状腺素水平与单核细胞人白细胞抗原DR(HLA-DR)表达的变化,并评价其临床意义.方法 125例住院的老年脓毒症非甲状腺疾病患者按照2001年国际脓毒症定义讨论公报分为非重症脓毒症组(在后面均简称脓毒症组,n=86)、重症脓毒症组(n=39),另设30例老年健康体检者为对照组;用化学发光法检测患者的血清甲状腺素水平,同时用流式细胞仪检测患者外周血单个核细胞(PBMC)表面HLA-DR分子的表达,比较各组之间的差别.结果 与对照组及脓毒症组比较,重症脓毒症组的三碘甲状腺原氨酸(T_3)、四碘甲状腺原氨酸(T_4)、游离三碘甲状腺原氨酸(FT_3)、游离四碘甲状腺原氨酸(FT_4)水平均明显减低(P<0.05),促甲状腺素(TSH)无显著变化(P>0.05),HLA-DR表达显著减低(P<0.05);与对照组比较,脓毒症组T_3、T_4、FT_3、FT_4、TSH水平也明显减低(P<0.05),HLA-DR也显著减低(P<0.05);其中重症脓毒症死亡组(放弃治疗或死亡)T_3、T_4、FT_3、FT_4水平及HLA-DR的表达明显低于存活组(转入普通病房)(P<0.05).结论 老年脓毒症患者随脓毒症病情的加重,血清甲状腺素水平与HLA-DR表达的变化呈明显下降趋势,联合二者可较好反映脓毒症的严重程度及预后.
目的 探討老年膿毒癥患者血清甲狀腺素水平與單覈細胞人白細胞抗原DR(HLA-DR)錶達的變化,併評價其臨床意義.方法 125例住院的老年膿毒癥非甲狀腺疾病患者按照2001年國際膿毒癥定義討論公報分為非重癥膿毒癥組(在後麵均簡稱膿毒癥組,n=86)、重癥膿毒癥組(n=39),另設30例老年健康體檢者為對照組;用化學髮光法檢測患者的血清甲狀腺素水平,同時用流式細胞儀檢測患者外週血單箇覈細胞(PBMC)錶麵HLA-DR分子的錶達,比較各組之間的差彆.結果 與對照組及膿毒癥組比較,重癥膿毒癥組的三碘甲狀腺原氨痠(T_3)、四碘甲狀腺原氨痠(T_4)、遊離三碘甲狀腺原氨痠(FT_3)、遊離四碘甲狀腺原氨痠(FT_4)水平均明顯減低(P<0.05),促甲狀腺素(TSH)無顯著變化(P>0.05),HLA-DR錶達顯著減低(P<0.05);與對照組比較,膿毒癥組T_3、T_4、FT_3、FT_4、TSH水平也明顯減低(P<0.05),HLA-DR也顯著減低(P<0.05);其中重癥膿毒癥死亡組(放棄治療或死亡)T_3、T_4、FT_3、FT_4水平及HLA-DR的錶達明顯低于存活組(轉入普通病房)(P<0.05).結論 老年膿毒癥患者隨膿毒癥病情的加重,血清甲狀腺素水平與HLA-DR錶達的變化呈明顯下降趨勢,聯閤二者可較好反映膿毒癥的嚴重程度及預後.
목적 탐토노년농독증환자혈청갑상선소수평여단핵세포인백세포항원DR(HLA-DR)표체적변화,병평개기림상의의.방법 125례주원적노년농독증비갑상선질병환자안조2001년국제농독증정의토론공보분위비중증농독증조(재후면균간칭농독증조,n=86)、중증농독증조(n=39),령설30례노년건강체검자위대조조;용화학발광법검측환자적혈청갑상선소수평,동시용류식세포의검측환자외주혈단개핵세포(PBMC)표면HLA-DR분자적표체,비교각조지간적차별.결과 여대조조급농독증조비교,중증농독증조적삼전갑상선원안산(T_3)、사전갑상선원안산(T_4)、유리삼전갑상선원안산(FT_3)、유리사전갑상선원안산(FT_4)수평균명현감저(P<0.05),촉갑상선소(TSH)무현저변화(P>0.05),HLA-DR표체현저감저(P<0.05);여대조조비교,농독증조T_3、T_4、FT_3、FT_4、TSH수평야명현감저(P<0.05),HLA-DR야현저감저(P<0.05);기중중증농독증사망조(방기치료혹사망)T_3、T_4、FT_3、FT_4수평급HLA-DR적표체명현저우존활조(전입보통병방)(P<0.05).결론 노년농독증환자수농독증병정적가중,혈청갑상선소수평여HLA-DR표체적변화정명현하강추세,연합이자가교호반영농독증적엄중정도급예후.
Objective To investigate the changes of thyroxin and monoeyte human leukocyte antigen-DR expression in senior patients with sepsis and explore their clinical significance. Methods According to the 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions, 125 senior patients with sepsis free of thyroid conditions were divided into non-severe sepsis group (n=86) and severe sepsis group (n=39), with another 30 healthy subjects as the control. Thyroid function was assayed by chemoluminescence method in these patients and monocyte HLA-DR expression was determined by flow cytometry. Results Compared with the control group and non-severe sepsis cases, the levels of free T3 (FT3), free T4 (FT4), T3, T4 and monocyte HLA-DR expression were significantly lower in severe sepsis eases (P<0.05), but the levels of thyroid stimulating hormone (TSH) were comparable between the 3 groups (/9>0.05). The non-severe sepsis cases showed significantly lower levels of FT3, FT4, T3, T4, TSH and monocyte HLA-DR expression than the control group (P<0.05). In severe sepsis group, the levels of FT3, FT4, T3, T4 and monocyte HLA-DR expression showed significant differences between the fatal cases and surviving cases (P<0.05). Conclusion The levels of thyroxin and monocyte human leukocyte antigen-DR expression are obviously lower in senior patients with severe sepsis, and their detection may well indicate the severity of the condition and help make prognostic judgment.